Search results for "Hormonal"

showing 10 items of 136 documents

Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines.

2016

Summary Context Undescended testis is the most common endocrinological disease in the male newborn period. Incidence varies between 1.0% and 4.6% in full-term neonates, with rates as high as 45% in preterm neonates. Failure or delay of treatment can result in reduced fertility and/or increased testicular cancer risk in adulthood. Objective To provide recommendations for the diagnosis and treatment of boys with undescended testes which reduce the risk of impaired fertility and testicular cancer in adulthood. Evidence acquisition Embase and Pubmed were searched for all relevant publications, from 1990 to 2015 limited to English language. Data were narratively synthesized in light of methodolo…

Malemedicine.medical_specialtyBOYSNONPALPABLE TESTISUrologymedia_common.quotation_subjectmedicine.medical_treatment030232 urology & nephrologyMEDLINEUrologyFertilityContext (language use)CRYPTORCHID TESTISCHILDRENDiseaseOrchidopexy03 medical and health sciences0302 clinical medicineHUMAN CHORIONIC-GONADOTROPINTesticular cancerTESTICULAR DESCENT030225 pediatricsCryptorchidismmedicineHumansOrchiopexyTesticular cancermedia_commonGONADOTROPIN-RELEASING-HORMONEFERTILITY INDEXbusiness.industryIncidence (epidemiology)Infantmedicine.diseaseFertilityUndescended testisPediatrics Perinatology and Child HealthSURGICAL-MANAGEMENTHormonal therapybusinessORCHIOPEXYJournal of pediatric urology
researchProduct

Survival of Mycosis Fungoides in Patients in the Southeast of England

2004

<i>Background:</i> Mycosis fungoides (MF) is the most common skin lymphoma. The aetiology of MF remains unknown, and no therapy has to date significantly altered patient survival. <i>Objective:</i> The present study examines trends in survival of MF patients in a well-defined population-based disease group, namely patients registered over a 40-year period at the Thames Cancer Registry, Southeast England. <i>Methods:</i> The Thames Cancer Registry is a population-based registry, covering a population of approximately 14 million people. Data were taken from the Surveillance, Epidemiology and End Results cancer registry programme and the National Centre for …

Malemedicine.medical_specialtyPathologySkin NeoplasmsAntineoplastic Agents HormonalDermatologyCohort StudiesMycosis FungoidesSex FactorsResidence CharacteristicsEpidemiologymedicineHumansSezary SyndromeIn patientRegistriesSurvival rateAgedProportional Hazards ModelsMycosis fungoidesbusiness.industryProportional hazards modelAge FactorsMiddle AgedPrognosismedicine.diseaseDermatologyPeripheral T-cell lymphomaLymphomaSurvival RateEnglandPopulation SurveillanceEtiologyFemalebusinessFollow-Up StudiesSEER Program
researchProduct

Effects of heavy resistance/power training on maximal strength, muscle morphology, and hormonal response patterns in 60-75-year-old men and women.

2002

Eleven women (TRW; 64 ± 4 yrs) and ten men (TRM; 65 ± 5 yrs) participated in the strength/power training twice a week for 24 weeks. Basal concentrations of serum total and free testosterone, growth hormone (GH), dehydroepiandrosterone sulfate (DHEAS), cortisol and sex hormone binding globulin (SHBG) as well as acute responses of serum total and free testosterone, growth hormone (GH) were measured. Maximal 1RM strength in the squat, chair rise time and muscle fibre distribution and areas of type I and IIa and IIb of the vastus lateralis were also examined. 1RM squat increased in TRW by 26 (SDIO) % (p < .001), and in TRM by 35(7) % (p < .001) and chair rise time improved in both groups…

Malemedicine.medical_specialtyPhysiologyMuscle Fibers SkeletalMuscle hypertrophyBasal (phylogenetics)Muscle morphologyInternal medicineMaximal strengthmedicineHumansOrthopedics and Sports MedicineGonadal Steroid HormonesMuscle SkeletalExerciseTestosteroneAgedFree testosteronebusiness.industryHypertrophyMiddle AgedHormonesEndocrinologyGrowth HormoneFemalebusinessHormonal responseCanadian journal of applied physiology = Revue canadienne de physiologie appliquee
researchProduct

Outcome of radical prostatectomy for incidental carcinoma of the prostate

2009

OBJECTIVE To evaluate a contemporary series of patients with incidental prostate cancer detected by transurethral resection of the prostate (TURP) and undergoing radical prostatectomy (RP). PATIENTS AND METHODS Between 1998 and 2004, 1931 patients had TURP for obstructive voiding symptoms and suspected BPH. Incidental prostate cancer was found in 104 (5.4%); 26 of these patients had a RP. The pathological staging and treatment of these patients were reviewed retrospectively and the follow-up results obtained. RESULTS Of the 26 patients who had RP, 17 had T1a and nine had T1b carcinoma of the prostate. After RP, six (35%) in the T1a group had no residual tumour (pT0) and 11 (65%) had pT2 can…

Malemedicine.medical_specialtyProstate biopsyUrologymedicine.medical_treatmentPathological stagingProstatic HyperplasiaUrologyurologic and male genital diseasesProstate cancerProstatemedicineHumansAgedTransurethral resection of the prostateProstatectomyIncidental Findingsmedicine.diagnostic_testbusiness.industryProstatectomyProstatic NeoplasmsCancerMiddle AgedProstate-Specific Antigenmedicine.diseaseTreatment Outcomemedicine.anatomical_structureHormonal therapyEpidemiologic MethodsbusinessProstatismBJU International
researchProduct

Expression pattern of estroprogestinic receptors in sinonasal inverted papilloma

2017

// Agostino Serra 1 , Rosario Caltabiano 2 , Giacomo Spinato 3 , Salvatore Gallina 4 , Salvatore Caruso 5 , Venerando Rapisarda 6 , Paola Di Mauro 1 , Veronica Castro 1 , Angelo Conti 1 , Luisa Licciardello 1 , Luigi Maiolino 1 , Salvatore Lanzafame 2 , Salvatore Cocuzza 1 1 Department of Medical and Surgical Sciences and Advanced Technologies “G. Ingrassia”, ENT Section, University of Catania, Catania, Italy 2 Department of Medical and Surgical Sciences and Advanced Technologies “G. Ingrassia”, Section of Anatomic Pathology, University of Catania, Catania, Italy 3 ENT Department, Rovigo Provincial Hospital, Rovigo, Italy 4 Department of Experimental Biomedicine and Clinical Neurosciences, …

Malemedicine.medical_specialtyReceptor expressionNose NeoplasmsInverted papillomaMalignancyBenign tumor03 medical and health sciencesinverted papilloma0302 clinical medicineHuman papilloma viruhuman papilloma virusmedicineBiomarkers TumorHormonal receptor expression; Human papilloma virus; Immunohistochemistry; Inverted papilloma; Paranasal sinuses; OncologyHumanshormonal receptor expression030223 otorhinolaryngologyAgedRetrospective StudiesPapilloma Invertedbusiness.industryGeneral surgeryAnatomical pathologyMiddle Agedmedicine.diseaseSurgeryParanasal sinusesmedicine.anatomical_structureParanasal sinuseOtorhinolaryngologyOncologyReceptors EstrogenParanasal sinuses inverted papilloma human papilloma virus hormonal receptor expression immunohistochemistry030220 oncology & carcinogenesisimmunohistochemistryEtiologyFemaleNeoplasm Recurrence LocalbusinessReceptors ProgesteroneParanasal sinusesResearch Paper
researchProduct

Neuromuscular Performance and Hormonal Profile During Military Training and Subsequent Recovery Period.

2018

INTRODUCTION Military training loads may induce different physiological responses in garrison and field training and only a little is known about how short-time recovery, lasting a few days, affects neuromuscular fitness and hormonal profile. This study aimed to investigate the effects of garrison and field military service on neuromuscular performance and hormonal profile and to evaluate the effects of a 3-day recovery on those factors. METHODS Twenty healthy male soldiers (20 ± 1 years) participated in the study, which consisted of 4 days of garrison training [days (D) 1-4] and 7 days of military field training (Days 5-12) followed by a 3-day recovery period (Day 15). Serum hormone concen…

Maleneuromuscular performanceTime FactorsHydrocortisonepalautuminensubsequent recovery period0211 other engineering and technologiessotilaskoulutus02 engineering and technologyIsometric exerciseElectromyography03 medical and health sciencesRecovery periodYoung Adult0302 clinical medicineSex hormone-binding globulinAnimal scienceSex Hormone-Binding GlobulinMedicineHumansTestosterone030212 general & internal medicineMuscle Strengthta315military traininghormonaaliset vaikutuksetsuorituskyky021110 strategic defence & security studiesAnalysis of VariancebiologyKnee extensorsmedicine.diagnostic_testbusiness.industryhormonal profileSignificant differencePublic Health Environmental and Occupational HealthGeneral MedicineField trainingHormonesThyroxineMilitary Personnelbiology.proteinPhysical EnduranceNeuromuscular MonitoringbusinessEnergy MetabolismlihasvoimaHormonePhysical Conditioning HumanMilitary medicine
researchProduct

2021

ObjectiveLoss of sex hormones has been suggested to underlie menopause-associated increment in cardiovascular risk. We investigated associations of sex hormones with arterial stiffness in 19–58-years-old women. We also studied associations of specific hormonal stages, including natural menstrual cycle, cycle with combined oral contraceptives (COC) and menopausal status with or without hormone therapy (HT), with arterial stiffness.MethodsThis study includes repeated measurements of 65 healthy women representing reproductive (n=16 natural, n=10 COC-users) and menopause (n=5 perimenopausal, n=26 postmenopausal, n=8 HT-users) stages. Arterial stiffness outcomes were aortic pulse wave velocity (…

Mean arterial pressurebusiness.industryEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectmedicine.medical_treatmentPhysiologymedicine.diseaseMenopauseHormonal contraceptionTransgender hormone therapyArterial stiffnessMedicineHormone therapybusinessPulse wave velocityMenstrual cyclemedia_commonFrontiers in Endocrinology
researchProduct

Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive b…

2021

Abstract Breast Cancer (BC) is a leading cause of death in women, currently affecting 13% of female population worldwide. First-line clinical treatments against Estrogen Receptor positive (ER+) BC rely on suppressing estrogen production, by inhibiting the aromatase (AR) enzyme, or on blocking estrogen-dependent pro-oncogenic signaling, by targeting Estrogen Receptor (ER) α with selective Modulators/Degraders (SERMs/SERDs). The development of dual acting molecules targeting AR and ERα represents a tantalizing alternative strategy to fight ER + BC, reducing the incidence of adverse effects and resistance onset that limit the effectiveness of these gold-standard therapies. Here, in silico desi…

Molecular dynamicAntineoplastic Agents Hormonalmedicine.drug_classIn silicoEstrogen receptorBreast NeoplasmsMolecular dynamicsQM/MMBreast cancerbreast cancerDrug DiscoverymedicineHumansAromataseIC50Pharmacologychemistry.chemical_classificationbiologyAromatase InhibitorsMultitargetOrganic ChemistryEstrogen AntagonistsAromatase inhibitorGeneral Medicinemedicine.diseaseSERMEnzymechemistryEstrogenCell cultureSettore CHIM/03 - Chimica Generale E InorganicaSERDbiology.proteinCancer researchFemale
researchProduct

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide

2021

Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. Aim: The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: An individualized approach is required for the management of VVA. Topical low-dose estrogens are effective and also alleviate urinary incontinence and prevent recurrent urinary tract infections. W…

Non-Hormonal Preparationsmedicine.medical_specialtyChronic conditionmedicine.drug_classmedicine.medical_treatmentUrinary systemVaginal DiseasesUrinary incontinenceVulvovaginal atrophyGeneral Biochemistry Genetics and Molecular BiologyVulvovaginal Atrophy03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineHumansEndocrine system030212 general & internal medicineExpert Testimony030219 obstetrics & reproductive medicinebusiness.industryObstetrics and GynecologyEstrogensPostmenopauseTopical EstrogensAdministration IntravaginalEstrogenPractice Guidelines as TopicQuality of LifeFemaleVulvar DiseasesAtrophymedicine.symptombusinessAdjuvantMaturitas
researchProduct

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Pro…

2017

Abstract Background The androgen receptor splice variant 7 (AR-V7) is associated with resistance to hormonal therapy in castration-resistant prostate cancer (CRPC). Due to limitations of the methods available for AR-V7 analysis, the identification of a reliable detection method may facilitate the use of this biomarker in clinical practice. Objective To confirm AR-V7 as a predictor of resistance to hormonal therapy and develop a new approach to assess AR-V7 by highly sensitive digital droplet polymerase chain reaction (ddPCR) in plasma-derived exosomal RNA. Design, setting, and participants Plasma samples were collected from 36 CRPC patients before they began second-line hormonal treatment. …

Oncology0301 basic medicineMaleResistanceExosomeschemistry.chemical_compoundProstate cancer0302 clinical medicineProtein IsoformsNeoplasm MetastasisReceptorAged 80 and overProstate cancerMiddle AgedProstatic Neoplasms Castration-ResistantReceptors Androgen030220 oncology & carcinogenesisBenzamidesAdenocarcinomaBiomarker (medicine)Hormonal therapyAR-V7; Digital droplet PCR; Exosomes; Hormonal therapy; Pharmacogenetics; Prostate cancer; Resistance; UrologyAndrostenesHormonal therapymedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classUrologyCastration resistantAdenocarcinomaDisease-Free Survival03 medical and health sciencesSDG 3 - Good Health and Well-beingInternal medicineNitrilesPhenylthiohydantoinmedicineEnzalutamideHumansAgedDigital droplet PCRPlasma derivedbusiness.industryRNAAndrogen Receptor Splice Variant 7medicine.diseaseAndrogenEndocrinology030104 developmental biologychemistryPharmacogeneticsDrug Resistance NeoplasmCancer cellCancer researchRNAAR-V7businessPharmacogenetics
researchProduct